S. 2513 119th Congress Senate

OTC Monograph Drug User Fee Transparency Act

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to transparency and reporting regarding over-the-counter drug monograph activities, and for other purposes.

Introduced: July 29, 2025 Introduced by: Tim Kaine Democratic · Virginia See on congress.gov

Health

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jul 29, 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Jul 29, 2025

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now July 29, 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Bill text 1 version

Introduced in Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Health, Education, Labor, and Pensions Committee
Senate

Lobbying activity 4

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

EMERGENT STRATEGIES
for LIFE360 · California · 3rd Quarter 2026 (July 1 - Sep 30)
EMERGENT STRATEGIES
for LIFE360 · California · 2nd Quarter 2026 (Apr 1 - June 30)
HALEON US HOLDINGS LLC
for HALEON US HOLDINGS LLC · New Jersey · 4th Quarter 2025 (Oct 1 - Dec 31)
HALEON US HOLDINGS LLC
for HALEON US HOLDINGS LLC · New Jersey · 3rd Quarter 2025 (July 1 - Sep 30)

Bodies those filers lobbied

HOUSE OF REPRESENTATIVES
4 filings
SENATE
4 filings
Centers For Medicare and Medicaid Services (CMS)
2 filings
Commerce, Dept of (DOC)
2 filings
Food & Drug Administration (FDA)
2 filings
Health & Human Services, Dept of (HHS)
2 filings
Internal Revenue Service (IRS)
2 filings
State, Dept of (DOS)
2 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

Cite this page click to expand

APA

U.S. Congress. (2026). S. 2513: OTC Monograph Drug User Fee Transparency Act. 119th Congress. Open America. https://openamerica.io/bill/119-S-2513/

MLA

"S. 2513: OTC Monograph Drug User Fee Transparency Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-2513/.

Bluebook (legal)

S. 2513, 119th Cong. (2026), https://openamerica.io/bill/119-S-2513/.

Markdown link

[S. 2513: OTC Monograph Drug User Fee Transparency Act](https://openamerica.io/bill/119-S-2513/)